Sales decline 44.31% to Rs 4.06 crore
Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net loss of Rs 0.17 crore during the previous quarter ended June 2023. Sales declined 44.31% to Rs 4.06 crore in the quarter ended June 2024 as against Rs 7.29 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales4.067.29 -44 OPM %-12.32-2.06 -PBDT-0.50-0.15 -233 PBT-0.53-0.17 -212 NP-0.53-0.17 -212Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content